Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity

Kinarus Therapeutics Holding AG announced the signing of subordinated bridge loan agreements with existing shareholders to ensure further liquidity is available to Kinarus during the period of time required for bridging the pending transfer of funds pursuant to a CHF1.5 million convertible loan investment from ChaoDian Investment Management Co, in Kinarus.

Scroll to Top